01:19 PM EDT, 05/02/2024 (MT Newswires) -- NovoCure's ( NVCR ) shares were down 0.2% in recent Thursday trading after reporting a narrower loss and higher revenue in Q1.

The company reported a Q1 net loss of $0.36 per diluted share, narrower than the per-share a loss of $0.50 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.42.

Revenue for the quarter ended March 31 was $138.5 million, up from $122.2 million a year earlier.

Analysts surveyed by Capital IQ expected $131.5 million.

Price: 12.80, Change: +0.06, Percent Change: +0.47